PLAY PODCASTS
1st longer term tirzepatide study (3 years)
Episode 101

1st longer term tirzepatide study (3 years)

Drs. Karl and Spencer discuss the brand new 3 year study of tirzepatide in those with prediabetes along with a discussion on semaglutide treating osteoarthritis

Docs Who Lift

November 14, 202444m 41s

Audio is streamed directly from the publisher (injector.simplecastaudio.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

Drs. Karl and Spencer discuss the brand new 3 year study of tirzepatide in those with prediabetes along with a discussion on semaglutide treating osteoarthritis.

Learn:

  • If people lose weight and keep it off with tirzepatide
  • How many people regain weight after stopping the medicine
  • Long-term side effects
  • If semaglutide helps with osteoarthritis

Click here to read the tirzepatide study

Click here to read the semaglutide study


Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.